ReviewJournal of oncology practice2018
Contemporary Approaches to In-Transit Melanoma.
Review in Journal of oncology practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.Annals of surgical oncology · 2026Article
- Recent advancements in the diagnosis and treatment of acral melanoma.Journal of Zhejiang University. Science. B · 2024Review
- Great Debate: Limb Infusion for Melanoma: A Thing of the Past?Annals of surgical oncology · 2023Article
- Burden of Care for Patients With In-Transit Melanoma.The Journal of surgical research · 2023Article
- Article
- Management of In-Transit Metastases.Current oncology reports · 2022Review
- Oncolytic viruses in melanoma.Frontiers in bioscience (Landmark edition) · 2022Review
- In-transit metastatic cutaneous melanoma: current management and future directions.Clinical & experimental metastasis · 2022Review
- Prognostic factors for in-transit metastasis in patients with malignant melanoma.Medicine and pharmacy reports · 2022Article
- Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [European radiology · 2021Article
- Application of an indocyanine green surgical fluorescence imaging system in sentinel lymph node biopsy of acral malignant melanoma.Annals of translational medicine · 2021Article
- Molecular Aspects of the Isolated Limb Infusion Procedure.Biomedicines · 2021Review
- Effectiveness of preoperative ultrasound-guided charcoal tattooing for localization of metastatic melanoma.Ultrasonography (Seoul, Korea) · 2020Article
- Improved durable responses regardless of age following cytoreduction and "no-tourniquet" hyperthermic isolated limb chemotherapy for in transit melanoma of the extremity.American journal of surgery · 2019Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
In-transit melanoma represents a distinct disease pattern of heterogeneous superficial tumors. Many treatments have been developed specifically for this type of disease, including regional chemotherapy and a variety of directly injectable agents. Novel strategies include the intralesional delivery of oncolytic viruses and immunocytokines. The combination of intralesional or regional chemotherapy with systemic immune checkpoint inhibitors also is a promising approach. In the current review, we examine the general management of the workup of patients with in-transit disease, the range of available therapies, and recommendations for specific therapies for an individual patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.